Correlates of protection against SARS-CoV-2 in rhesus macaques
Author(s)
McMahan, Katherine; Yu, Jingyou; Mercado, Noe B.; Loos, Carolin; Tostanoski, Lisa H.; Chandrashekar, Abishek; Liu, Jinyan; Peter, Lauren; Atyeo, Caroline; Zhu, Alex Lee; Bondzie, Esther A.; Dagotto, Gabriel; Gebre, Makda S.; Jacob-Dolan, Catherine; Li, Zhenfeng; Nampanya, Felix; Patel, Shivani; Pessaint, Laurent; Van Ry, Alex; Blade, Kelvin; Yalley-Ogunro, Jake; Cabus, Mehtap; Brown, Renita; Cook, Anthony; Teow, Elyse; Andersen, Hanne; Lewis, Mark G.; Lauffenburger, Douglas A; Alter, Galit; Barouch, Dan H.; ... Show more Show less
DownloadAccepted version (2.282Mb)
Publisher Policy
Publisher Policy
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Terms of use
Metadata
Show full item recordAbstract
Recent studies have reported the protective efficacy of both natural1 and vaccine-induced2–7 immunity against challenge with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques. However, the importance of humoral and cellular immunity for protection against infection with SARS-CoV-2 remains to be determined. Here we show that the adoptive transfer of purified IgG from convalescent rhesus macaques (Macaca mulatta) protects naive recipient macaques against challenge with SARS-CoV-2 in a dose-dependent fashion. Depletion of CD8+ T cells in convalescent macaques partially abrogated the protective efficacy of natural immunity against rechallenge with SARS-CoV-2, which suggests a role for cellular immunity in the context of waning or subprotective antibody titres. These data demonstrate that relatively low antibody titres are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may contribute to protection if antibody responses are suboptimal. We also show that higher antibody titres are required for treatment of SARS-CoV-2 infection in macaques. These findings have implications for the development of SARS-CoV-2 vaccines and immune-based therapeutic agents.
Date issued
2020-12Department
Ragon Institute of MGH, MIT and Harvard; Massachusetts Institute of Technology. Department of Biological EngineeringJournal
Nature
Publisher
Springer Science and Business Media LLC
Citation
McMahan, Katherine et al. "Correlates of protection against SARS-CoV-2 in rhesus macaques." Nature 590, 7847 (December 2020): 630–634 © 2020 The Author(s).
Version: Author's final manuscript
ISSN
0028-0836
1476-4687